课题基金 / 基金详情

Study in Tissues Damage by Phenol and TCA Peels and clinical applications

Study in Tissues Damage by Phenol and TCA Peels and clinical applications
苯酚和TCA换肤术的组织损伤研究及临床应用
批准号:
15591188
负责人:
YAMAMOTO Yuki
金额:
$1.47万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

YAMAMOTO Yuki的其他基金

相似基金

相关文献

中文摘要
翻译
1.针对三氯乙酸(TCA)或苯酚处理皮肤的伤口愈合,我们研究了角蛋白6、7、10和16的表达模式以及人β 1整合素和腱生素的免疫组织化学分布。结果表明,三氯乙酸处理的皮肤和苯酚处理的皮肤的表皮组织学变化在苏木精-伊红染色的石蜡切片中非常相似,但显示免疫组化染色不同。然而,在真皮苯酚渗透到皮肤迅速,并诱导内皮细胞的变化和苯酚果皮可能不同于TCA果皮的组织学效应。在苯酚损伤的组织中,通过TUNEL方法和活化的Caspase-3的表达阳性检测到皮肤变性。然而,我们没有观察到p53或Fas的上调。同时TCA剥离皮肤显示阳性反应的TUNEL法,但不通过Caspase-3激活,Fas,或p53。这些结果表明,苯酚剥脱后的皮肤退化将通过激活Caspase-3导致细胞凋亡,这与TCA剥脱后的皮肤退化不同.对拒绝手术或手术困难的老年皮肤肿瘤患者,采用三氯乙酸(TCA)和/或苯酚皮片治疗,并随访1 ~ 4年。结果我们认为,光化性角化病(AK)、Bowen病和组织学浅表型基底细胞癌(BCC)可望用TCA和/或苯酚皮完全治愈。部分患者(2例AK和2例Bowen病)对治疗耐药。这些患者的肿瘤细胞在治疗过程中显示出强烈的p-53表达。
英文摘要
1. In view of wound healing in trichloroacetic acid(TCA) or phenol treated skin, we studied the expression patterns of keratin 6, 7, 10 and 16 and the immunohistochemical distribution of human beta-1 integrin and tenascin. In our result, histological changes of epidermis in TCA treated skin and phenol treated skin were very similar in the hematoxyline-eosin stained paraffin sections, but shows that the immunohistochemical stainings were differed. However, in the dermis phenol penetrated into the skin quickly and induced changes in endothelial cells and the phenol peels might differ from histological effects of TCA peels. In tissues damaged with phenol, skin degenerations were positively detected by a TUNEL method and expression of activated Caspase-3. However, we did not observe up-regulation of p53 or Fas. Meanwhile TCA peeled skins showed positive reaction by a TUNEL method, but not by Caspase-3 activation, Fas, or p53. These findings suggest that skin degenerations after phenol peels will lead to apoptosis via Caspase-3 activation, which differs from skin degenerations after TCA peels.2. In aged patients with skin tumor who refused the operation or had the difficulty in the surgery, we used TCA and/or phenol peels as a treatment and followed the clinical and histological course of them for one to 4 years. In the result we thought complete cure with TCA and/or phenol peels were expected for actinic keratosis(AK), Bowen's disease and basal cell carcinoma(BCC) of histologically superficial type. Some patients (2 AK and 2 Bowen's disease) were resistant to the therapy. The tumor cells in these patients showed strongly expression of p-53 during the course of the treatment.
期刊论文(46)
专著(0)
科研奖励(0)
会议论文
皮膚小腫瘍のケミカルピーリング、今すぐ出来る皮膚小手術、処置のテクニック
小皮肤肿瘤的化学换肤术、可立即进行的小型皮肤手术以及治疗技术
DOI: --
发表时间: 2004
期刊:
影响因子: --
作者: [Kanekura T, Hiraishi K, Kawahara K, Maruyama I, Kanzaki T., Kanekura T et al., 山本有紀, Yamamoto Y, 山本有紀, 山本有紀, 山本有紀, Yamamoto Y, Yamamoto Y, Yamamoto Y, 山本有紀, 山本有紀, Yamamoto Y, Yamamoto Y, Yamamoto Y, 山本有紀]
通讯作者: 山本有紀
日本皮膚科学会ケミカルピーリングガイドライン2001準拠 ケミカルピーリングこれが私のコツと技
符合日本皮肤病学会 2001 年化学换肤指南 化学换肤:这些是我的提示和技巧
DOI: --
发表时间: 2003
期刊:
影响因子: --
作者: [Kanekura T, Hiraishi K, Kawahara K, Maruyama I, Kanzaki T., Kanekura T et al., 山本有紀, Yamamoto Y, 山本有紀, 山本有紀, 山本有紀, Yamamoto Y, Yamamoto Y, Yamamoto Y, 山本有紀, 山本有紀, Yamamoto Y, Yamamoto Y, Yamamoto Y, 山本有紀, 山本有紀, 山本有紀]
通讯作者: 山本有紀
山本有紀, 古川福実: "日本皮膚科学会ケミカルピーリングガイドライン2001準拠 ケミカルピーリング これが私のコツと技"南山堂. 19 (2003)
Yuki Yamamoto、Fukumi Furukawa:“根据日本皮肤病学协会 2001 年化学换肤指南进行的化学换肤:这些是我的技巧和技术”Nanzando 19 (2003)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
P-cadherin Expression in Skin Peeled with Phenol or Trichloroacetic Acid (TCA).
用苯酚或三氯乙酸 (TCA) 剥皮的皮肤中 P-钙粘蛋白的表达。
DOI: --
发表时间: 2003
期刊: J Dermatol 30
影响因子: --
作者: [Kanekura T, Hiraishi K, Kawahara K, Maruyama I, Kanzaki T., Kanekura T et al., 山本有紀, Yamamoto Y, 山本有紀, 山本有紀, 山本有紀, Yamamoto Y, Yamamoto Y, Yamamoto Y]
通讯作者: Yamamoto Y
共 23 条
    Economic analysis of forest fire in Indonesia: Policy evaluation with randomized field experiment.
    • 批准号:
      16K17127
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.41万
    • 财政年份:
      2016
    • 负责人:
      YAMAMOTO Yuki
    • 依托单位:
    Establishment and analysis of cancer stem cell and induced cancer stem cell of refractory pediatric solid organ neoplasm.
    海外基金